Estrella Immunopharma (ESLA) Q2 2025 Earnings

14MayConfirmed
Q4 2024
Q1 2025
Q2 2025
-0.12
-0.12
-0.11
-0.11

Details

Expected EPS
-0.11
Actual EPS
-0.11
Surprise EPS
0
Surprise Percent
+0%

Description

Estrella Immunopharma (ESLA) has reported earnings of -0.11 per share for Q2 2025.

0 Comments

Share your thoughts